Research Studies

Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia (CAP): a randomised double blind controlled trial: CAP-IT

Start Date
04 Jan 2018
End Date
31 Apr 2019
Co-ordinated by
University College London
Local PI
Dr Chris Gough
Lead Research Practitioner
Louise Conner

This study investigated the best dose and duration of Oral Amoxicillin for children with Community Acquired Pneumonia (CAP) being discharged home from the Emergency Department. There were four potential study arms High dose (250mg) Amoxicillin over four days or high dose Amoxicillin over seven days, Low dose Amoxicillin (125mg) over four days or Low dose over seven days.

We are hoping to find out the results of this trial in the next few months.